Home/Filings/4/0001214659-18-003872
4//SEC Filing

Drake Neil 4

Accession 0001214659-18-003872

CIK 0001427570other

Filed

May 16, 8:00 PM ET

Accepted

May 17, 7:18 PM ET

Size

5.4 KB

Accession

0001214659-18-003872

Insider Transaction Report

Form 4
Period: 2018-05-15
Drake Neil
VP of Research and Development
Transactions
  • Award

    Common Stock (Restricted Stock Award)

    2018-05-15+17,93817,938 total
Holdings
  • Common Stock

    29,593
Footnotes (1)
  • [F1]The Restricted Shares shall vest as to 100% of the Shares underlying the Award on January 2, 2020, subject to the reporting person's provision of service to the Issuer.

Issuer

OBALON THERAPEUTICS INC

CIK 0001427570

Entity typeother

Related Parties

1
  • filerCIK 0001698005

Filing Metadata

Form type
4
Filed
May 16, 8:00 PM ET
Accepted
May 17, 7:18 PM ET
Size
5.4 KB